Decrease of epstein-barr virus anti early antigen imunoglobulin a levels and primary tumor size in post-cisplatin-paclitaxel chemotherapy in nasopharyngeal carcinoma patients
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Decrease of epstein-barr virus anti early antigen imunoglobulin a levels and primary tumor size in post-cisplatin-paclitaxel chemotherapy in nasopharyngeal carcinoma patients'. Together they form a unique fingerprint.